Technetium, as they called it, was the last of elements 1-92 to be tracked down, and in fact it had to be synthesized rather than isolated from naturally occurring sources.
Technetium-99m radiopharmaceuticals will continue to have a significant impact in several areas of nuclear medicine. This publication is intended to provide a broad overview of the current status of ...
Technetium-99m (99mTc) is used in approximately 85% of diagnostic imaging procedures in nuclear medicine worldwide. Interruptions in the supply of molybdenum (99Mo), which is used to produce 99mTc, ...
Review the side-effects of Technetium Tc99m Exametazime Injection as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...
Technetium-99m (⁹⁹ᵐTc) is a metastable nuclear isomer of technetium-99 (itself an isotope of technetium), symbolized as ⁹⁹ᵐTc, that is used in tens of millions of medical diagnostic ...
For example, rhenium is both a valuable metal used as a catalyst and an analog for technetium, a radioactive element which is hard to separate from nuclear waste, making rhenium capture of great ...
Review the side-effects of Technetium Tc99m Sestamibi as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.
Rhenium and technetium not only share the same group in the periodic table, but also have some common history relating to how they were — or indeed weren't — discovered. Eric Scerri explains.
Radioactive Technetium-99m is used in medicine to image the skeleton and heart and has a six-hour half-life. If it is injected into a patient and considered to be safe in 10 half-lives ...
One of the reasons promethium was so elusive for a relatively low atomic number element is that it doesn't have a stable state - it's one of only two elements below 83 that only has radioactive ...
Among them, sodium fluorine injection has completed clinical trials and was submitted for new drug application; iodine-MIBG injection was in Phase III clinical trial; technetium sulfide colloidal ...